LAV Fund VI L.P. 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:20 pm Purchase |
2024-01-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
LAV Fund VI L.P. | 2,046,123 6.400% |
2,046,123 (New Position) |
Filing |